Related Experiment Video
Updated: Dec 9, 2025
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Constructing a Biomaterial to Simulate Extracellular Drug Transport in Solid Tumors
Sebastian G Huayamares1, Jimmy Y Song2, Aric Huang2
1Bioengineering Graduate Program, University of Kansas, Lawrence, KS, 66045, USA.
Abstract:
Designing an in vitro model of the tumor extracellular microenvironment to screen intratumoral drugs is an active challenge. As recent clinical successes of human intratumoral therapies stimulate research on intratumoral delivery, a need for a 3D tumor model to screen intratumoral therapies arises. When injecting the drug formulation directly into the tumor, the biophysics affecting intratumoral retention must be considered; especially for biologic therapies, which may be dominated by extracellular transport mechanisms. Fibrotic regions in solid tumors are typically rich in collagen I fibers. Using shear rheology, head and neck tumors with higher collagen density show a higher stiffness. Similarly, the stiffness of the hyaluronic acid (HA) hydrogel models is increased by adding collagen fibers to model the bulk biomechanical properties of solid tumors. HA hydrogels are then used as intratumoral injection site simulators to model in vitro the retention of glatiramer acetate (GA) and polyethylene glycol (PEG) administered intratumorally. Both compounds are also injected in murine tumors and retention is studied ex vivo for comparison. Retention of GA in the hydrogels is significantly longer than PEG, analogous to the solid tumors, suggesting the utility of HA hydrogels with collagen I fibers for screening extracellular drug transport after intratumoral administration.
Insights
A novel 3D hyaluronic acid hydrogel model with collagen I fibers effectively simulates tumor extracellular microenvironments. This model accurately predicts intratumoral drug retention, aiding in the development of new cancer therapies.
Area of Science:
- Biomaterials Science
- Cancer Biology
- Drug Delivery
Background:
- Developing in vitro models for screening intratumoral drugs is crucial due to advances in intratumoral therapies.
- Tumor extracellular microenvironment biophysics, particularly collagen I fiber density and stiffness, significantly impact drug retention.
- Existing models often lack the complexity to accurately represent the mechanical properties of solid tumors.
Purpose of the Study:
- To design and validate a 3D in vitro model simulating the tumor extracellular microenvironment for drug screening.
- To investigate the retention of glatiramer acetate (GA) and polyethylene glycol (PEG) in a novel hyaluronic acid (HA) hydrogel model.
- To compare in vitro hydrogel retention with ex vivo murine tumor retention data.
Main Methods:
- Fabrication of hyaluronic acid (HA) hydrogels with varying concentrations of collagen I fibers to mimic tumor stiffness.
- Rheological analysis to characterize the biomechanical properties of the hydrogel models.
- In vitro assessment of glatiramer acetate (GA) and polyethylene glycol (PEG) retention within the HA-collagen hydrogels.
- Ex vivo analysis of GA and PEG retention in murine tumors following intratumoral injection.
Main Results:
- Increased collagen I fiber density in HA hydrogels significantly enhanced their stiffness, replicating tumor biomechanics.
- Glatiramer acetate (GA) exhibited significantly longer retention in the HA-collagen hydrogels compared to polyethylene glycol (PEG).
- The in vitro retention patterns of GA and PEG in the hydrogel model closely mirrored their retention observed in ex vivo murine tumors.
Conclusions:
- Hyaluronic acid hydrogels incorporating collagen I fibers serve as effective in vitro simulators for intratumoral injection sites.
- This model accurately predicts extracellular drug transport and retention following intratumoral administration, particularly for biologic therapies.
- The developed model offers a valuable platform for screening intratumoral drug efficacy and optimizing delivery strategies.
